Comparing Blood Disorders Among Patients With Hepatitis C Who Recently Received The Combined Interferon and Ribavirin Therapy and Those Who did not
Asmaa Mohammed Elsayed Eissa;
Abstract
Hepatitis C has infected nearly 170 million people worldwide; Egypt has the highest prevalence for HCV.
There are various extra hepatic manifestations of HCV infection, hematological and non hematological, such as pulmonary fibrosis, cutaneous vasculitis
There are various extra hepatic manifestations of HCV infection, hematological and non hematological, such as pulmonary fibrosis, cutaneous vasculitis
Other data
| Title | Comparing Blood Disorders Among Patients With Hepatitis C Who Recently Received The Combined Interferon and Ribavirin Therapy and Those Who did not | Other Titles | مقارنة الإعتلالات الدموية بين المرضى المصابين بفيروس "ج" الذين تم معالجتهم بالإنترفيرون والريبافيرين والذين لم يتلقوا هذا العلاج | Authors | Asmaa Mohammed Elsayed Eissa | Keywords | Comparing Blood Disorders Among Patients With Hepatitis C Who Recently Received The Combined Interferon and Ribavirin Therapy and Those Who did not | Issue Date | 2011 | Description | Hepatitis C has infected nearly 170 million people worldwide; Egypt has the highest prevalence for HCV. There are various extra hepatic manifestations of HCV infection, hematological and non hematological, such as pulmonary fibrosis, cutaneous vasculitis |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 106992p4363.pdf | 1.6 MB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.